The United States Food and Drug Administration says the shortage ... pharmacies and online companies need to stop selling off-brand versions of the weight-loss drugs. The FDA has issued warnings ...
The Food and Drug Administration said that a nationwide ... to phase out their products. Off-brand copies of the GLP-1 drugs were used during a shortage of Zepbound and Mounjaro.
Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...